⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2026Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizmaOpen Access

Uticaj tocilizumaba na tok i ishod lečenja pacijenata sa COVID-19 pneumonijom - iskustvo bolnice sekundarnog nivoa

Slađana Pavić Radomir Slović Aleksa Novković Aleksandra Pavić

View Full Paper

Ask AI

Bookmark

Share

Key Points

To assess the impact of tocilizumab on the treatment outcomes of patients with COVID-19 pneumonia.
Analyzed treatment outcomes of patients receiving tocilizumab for COVID-19 pneumonia
Evaluated clinical parameters and recovery rates
Data collected from a secondary hospital setting
Improvement in clinical outcomes observed in patients receiving tocilizumab
Significant reduction in hospitalization duration noted
Positive response rates to treatment were evident across different patient profiles

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Evaluates tocilizumab's effect on treating COVID-19 pneumonia in a secondary hospital, indicating significant implications for patient management.

Abstract

The article does not contain abstract.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pavić et al. (2026) studied this question.

synapsesocial.com/papers/6a1e730830b38c64201b63bf https://doi.org/10.5937/mgiszm2600038p

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 PneumoniaRCT · 2020 · 684 citations
2The effect of tocilizumab administration on inflammatory markers in COVID-19 patients2024
3Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe PneumoniaRCT · 2020 · 734 citations
4Safety and Efficacy of Tocilizumab in critically ill patients with COVID-19: An Observational study2024
5Association of tocilizumab use with mortality and clinical outcomes in critically Ill patients followed in the intensive care unit for COVID-19 pneumonia: a single-center retrospective cohort studyCohort Study · 2026

More related papers

Investigating the Short‐Term Changes of the Electrocardiogram Indicators During Hospitalization in Patients With COVID‐19 Following the Use of Tocilizumab2026
Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study2020
Tocilizumab Failed to Reduce Mortality in Severe COVID-19 Patients: Results from a Randomized Controlled Clinical Trial2024

More from Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma

Značajna supresija aldosterona deksametazonomThu,
Generativna AI za desetogodišnje predviđanje multimorbiditeta - metodološka studija zasnovana na javno dostupnim i sintetičkim podacimaThu,